BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2559394)

  • 21. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of plasma aldosterone by chronic ACTH administration is offset by converting enzyme inhibitor.
    Fukuda N; Honda M; Watanabe M; Minato M; Hatano M
    Endocrinol Jpn; 1987 Oct; 34(5):665-73. PubMed ID: 2830100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
    Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
    Richer C; Bruneval P; Ménard J; Giudicelli JF
    Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the mechanism of action of angiotensin converting enzyme inhibitors on the dog kidney].
    Omosu M
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):883-94. PubMed ID: 1484407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feedback analysis of the behavior of the renin-angiotensin system under inhibition of angiotensin-converting enzyme.
    Wada T; Aoyagi T; Iinuma H; Ogawa K; Kojima F; Nagai M; Kuroda H; Obayashi A; Takeuchi T
    Biotechnol Appl Biochem; 1988 Oct; 10(5):435-46. PubMed ID: 3058152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and pharmacology of angiotensin converting enzyme inhibitors.
    Antonaccio MJ
    J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II.
    Saito H; Nakamaru M; Ogihara T; Rakugi H; Kumahara Y; Shimamoto K; Miyazaki M; Inagami T
    Hypertension; 1989 Jun; 13(6 Pt 2):749-53. PubMed ID: 2661430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
    Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal responses to antagonism of the renin-angiotensin system.
    Braam B; Koomans HA
    Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):89-96. PubMed ID: 8834166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis.
    Beierwaltes WH; Carretero OA
    Hypertension; 1989 Jun; 13(6 Pt 2):754-8. PubMed ID: 2544521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the brain renin-angiotensin system in blood pressure regulation.
    Varoni MV; Palomba D; Demontis MP; Gianorso S; Pais GL; Anania V
    Vet Res Commun; 2007 Aug; 31 Suppl 1():343-6. PubMed ID: 17682910
    [No Abstract]   [Full Text] [Related]  

  • 39. Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure.
    Fujii M; Wada A; Ohnishi M; Tsutamoto T; Matsumoto T; Yamamoto T; Takayama T; Dohke T; Isono T; Eguchi Y; Horie M
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S346-9. PubMed ID: 15838317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.